FIGURE 2.
Percentage of 70 patients with chronic hepatitis C (CHC) and 112 with cirrhosis showing haemoglobin (HbA1c) values < 7.2 g/dL at baseline, and at 48, 96 and 120 weeks after stopping direct‐acting antiviral (DAA) treatments
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.